CMP Brace

Description

The CMP Night Brace has recently been selected as part of the BASIS Study, a 10 year national trial into the effects and outcomes of night-time versus full-time bracing in adolescent idiopathic scoliosis.

The BASIS Study is a 10-year national trial within the UK into the effects and outcomes of night-time versus full-time bracing in adolescent idiopathic scoliosis.

The BASIS Study is trying to find out which type of back brace is best for treating children and young people with scoliosis.

The study is comparing two different types of back brace, one which is worn for at least 20 hours a day (full-time bracing), and one which is worn only at night-time (night-time bracing).

We are very proud that our CMP night brace has been selected as one of the night-time braces that is being used in the BASIS study.

You can learn more about the BASIS Study here: http://basisstudy.org/

UNIQUE CURVE CLASSIFICATION SYSTEM

Unlike the simple classification systems used by other brace designs, CMP Brace curve classification is ultra-specific, considering far more than just the number of curves, spinal levels and direction. The CMP Brace classification differentiates between Primary Structural, Secondary Structural and Compensatory Curves, allowing optimally focused brace design.

CORRECTIVE MOVEMENT PRINCIPLE

This ultimate 3D, postural over-correction, asymmetrical brace, benefits from curve classification and correction principles which offer optimally focused correction. Both the Curve Classification and Corrective Movement Principle, developed in the mid 90’s, have been clinically proven to be effective in more than 25 independent clinical brace trials.

EXPERT DESIGN

Each brace is designed by our specialist Scoliosis Clinical Team, collectively having over 75 years’ experience in scoliosis bracing. Our in-house design team use the latest CAD/CAM technology to individually design each patient’s brace.

TREATMENT SUCCESS

The SpineCorporation is proud to make our CMP Brace, developed and tested over the past decade, available worldwide, following significant local treatment success.